Diabetes MellitusJohn A. Galloway, Janet H. Potvin, Charles R. Shuman Lilly Research Laboratories, 1988 - 335 pages |
From inside the book
Results 1-3 of 13
Page 163
... SMBG have enthusiastically endorsed the concept . 33 Since the initial reports , 26-32 at least three international symposia have been held on SMBG , and the practice has gained widespread accep- tance among diabetologists and patients ...
... SMBG have enthusiastically endorsed the concept . 33 Since the initial reports , 26-32 at least three international symposia have been held on SMBG , and the practice has gained widespread accep- tance among diabetologists and patients ...
Page 166
... SMBG determinations . After one year of intensive therapy , HbA , values were near normal ( “ Initial ” ) . Patients had been per- forming SMBG ≥4 times daily . During the next six months ( " No Contact " ) , patients mon- itored their ...
... SMBG determinations . After one year of intensive therapy , HbA , values were near normal ( “ Initial ” ) . Patients had been per- forming SMBG ≥4 times daily . During the next six months ( " No Contact " ) , patients mon- itored their ...
Page 167
... SMBG . 48 SMBG may result in fewer hospitalizations , thus in overall cost savings . However , careful cost - benefit studies have not been reported , except in patients during pregnancy . 49.50 The long - term potential benefits of SMBG ...
... SMBG . 48 SMBG may result in fewer hospitalizations , thus in overall cost savings . However , careful cost - benefit studies have not been reported , except in patients during pregnancy . 49.50 The long - term potential benefits of SMBG ...
Contents
Definition | 1 |
Chapter 2 iabetes Mellitus and Heredity | 15 |
Chapter 3 athophysiology of Diabetes Mellitus | 27 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities action activity agents antibodies associated betes blood glucose blood glucose concentrations body carbohydrate cause cells changes Chapter clinical complications continuous daily decrease determinations diabetes mellitus diabetic diet diabetic ketoacidosis diagnosis diet disease dose early effect exercise factors Figure given glucose tolerance glycemic glycosylated hemoglobin hormone human insulin hypoglycemia impaired important improved increased indicated individuals initial injection insulin infusion insulin receptor insulin resistance insulin secretion insulin therapy insulin-dependent levels lipoprotein liver meals measure metabolic methods mg/dl mmol/L monitoring muscle myocardial infarction needed normal obese occur oral patients with diabetes patients with Type plasma glucose pregnancy prevent production protein pump receptor reduced regular renal reported response retinopathy risk severe Source studies subcutaneous subjects Table therapy tion tissue treated treatment Type I diabetes Type II units urine usually values weight